Delivery Order SPE2DB22D2007-SPE2DB25FJ3FE
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $33,700.47 for NURTEC ODT 75 mg tablets (8-count units) on August 25, 2025, with completion anticipated by August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) valued at $14,433.09. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a $3,655.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on June 6, 2025, with completion scheduled for June 9, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a $24,953.82 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a $20,329.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 MG tablets (eight-count units). The contract, which is non-set-aside and competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $21,080.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-competitive award to the prime contractor and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, consistent with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $5,362.99. This firm fixed price delivery order, which is due for completion by August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The award was made...
- The Defense Logistics Agency awarded a $18,492.01 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (quantity 8). This contract, with an ultimate completion date of September 4, 2025, represents a competitive award with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and operates as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a $37,622.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for the acute treatment of migraine in adults and represents one of many...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3FEDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $50,511.39 for NURTEC ODT 75 mg tablets (8-count packaging) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, and this delivery order supports the Defense Health Agency's pharmaceutical supply chain requirements for military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, maintains extensive federal contract portfolios delivering brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's competitively awarded federal contracts demonstrate its capability to fulfill diverse military healthcare pharmaceutical needs through both large-value prime vehicles and individual delivery orders with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.5k | 7/22/25 |